Eli Lilly (LLY) Stock After the $1 Trillion Milestone: Latest News, Analyst Targets and 2026 Outlook
On November 21, 2025, Eli Lilly and Company (NYSE: LLY) became the first pharmaceutical group ever to cross a $1 trillion market value, lifted by surging demand for its obesity and diabetes drugs Mounjaro and Zepbound. Reuters+2Financial Times+2 Since then,